skip to Main Content

Optical Imaging Reveals how Cancer Cells Hijack Metabolic Activity to fuel Pancreatic Tumor Growth

Newsfeed image, light gray text on dark gray background
Pancreatic cancer is a rare, yet elusive and deadly cancer, with a five-year survival rate of about 10%. If the cancer has metastasized, that rate lowers to 3%. And treatment options are extremely limited.

“It’s one of the scarier cancers because once you discover that a person has pancreatic cancer, it’s often too late because there are no symptoms,” says Rupsa Datta, an assistant scientist in the Skala Lab. “The survival rate is so low because at that point, you can’t really do anything.” Read more . . . 


Back To Top